Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss
Christopher J. Klein(Mayo Clinic), Julie M. Cunningham(Cancer Research UK), P. James B. Dyck(Mayo Clinic), Simon Hammans(Essex Cardiothoracic Centre), Maria Victoria Botuyan(Mayo Clinic), Kaori Hojo, William J. Litchy(Mayo Clinic), Hiromitch Yamanishi, Elizabeth J. Atkinson(Mayo Clinic in Arizona), Adam R. Karpf(University of Nebraska Medical Center), Georges Mer(Mayo Clinic), Benjamin Boes(Roche (Sweden)), Sumit Middha(Memorial Sloan Kettering Cancer Center), Cecilie M. Lander(The University of Queensland), Glenn E. Smith(University of Florida Health), Garth A. Nicholson(Concord Repatriation General Hospital), Mariella Simon(University of California, Irvine), Douglas C. Wallace(Children's Hospital of Philadelphia), Yanhong Wu(Shandong University of Technology), Joseph E. Parisi(Mayo Clinic), Christopher J. Ward(University of Kansas Medical Center)
Cited by 399
Related Papers
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|1.4k
Genome partitioning of genetic variation for complex traits using common SNPs
|Nature Genetics|2011|966